Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Amortization - Intangibles (2016 - 2020)

Historic Amortization - Intangibles for Avadel Pharmaceuticals (AVDL) over the last 6 years, with Q2 2020 value amounting to $203000.0.

  • Avadel Pharmaceuticals' Amortization - Intangibles fell 49.02% to $203000.0 in Q2 2020 from the same period last year, while for Mar 2021 it was $203000.0, marking a year-over-year decrease of 7518.34%. This contributed to the annual value of $406000.0 for FY2020, which is 5024.51% down from last year.
  • Per Avadel Pharmaceuticals' latest filing, its Amortization - Intangibles stood at $203000.0 for Q2 2020, which was down 49.02% from $203000.0 recorded in Q1 2020.
  • In the past 5 years, Avadel Pharmaceuticals' Amortization - Intangibles ranged from a high of $3.7 million in Q2 2016 and a low of $201000.0 during Q1 2019
  • Its 5-year average for Amortization - Intangibles is $1.4 million, with a median of $1.1 million in 2017.
  • Its Amortization - Intangibles has fluctuated over the past 5 years, first surged by 21329.79% in 2018, then tumbled by 8862.48% in 2019.
  • Over the past 5 years, Avadel Pharmaceuticals' Amortization - Intangibles (Quarter) stood at $3.0 million in 2016, then plummeted by 33.77% to $2.0 million in 2017, then dropped by 17.49% to $1.6 million in 2018, then plummeted by 87.31% to $206000.0 in 2019, then dropped by 1.46% to $203000.0 in 2020.
  • Its last three reported values are $203000.0 in Q2 2020, $203000.0 for Q1 2020, and $206000.0 during Q4 2019.